GROW Fundamental Analysis - GROWENS SPA

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to GROW. GROW was compared to 101 industry peers in the Software industry. While GROW seems to be doing ok healthwise, there are quite some concerns on its profitability. GROW does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year GROW has reported negative net income.

GROW had a negative operating cash flow in the past year.

In multiple years GROW reported negative net income over the last 5 years.

The reported operating cash flow has been mixed in the past 5 years: GROW reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -4.08%, GROW is doing worse than 65.35% of the companies in the same industry.

The Return On Equity of GROW (-7.05%) is worse than 62.38% of its industry peers.

		Industry Rank	Sector Rank
ROA	-4.08%
ROE	-7.05%
ROIC	N/A

ROA(3y)20.87%

ROA(5y)12.86%

ROE(3y)26.81%

ROE(5y)17.18%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

GROW has a Gross Margin of 22.38%. This is amonst the worse of the industry: GROW underperforms 83.17% of its industry peers.

In the last couple of years the Gross Margin of GROW has declined.

GROW does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	22.38%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-9.85%

GM growth 5Y-2.53%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

GROW does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for GROW remains at a similar level compared to 1 year ago.

GROW has less shares outstanding than it did 5 years ago.

The debt/assets ratio for GROW is higher compared to a year ago.

2.2 Solvency

GROW has an Altman-Z score of 3.45. This indicates that GROW is financially healthy and has little risk of bankruptcy at the moment.

The Altman-Z score of GROW (3.45) is comparable to the rest of the industry.

GROW has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.

GROW has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. GROW outperforms 80.20% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.06
Debt/FCF	N/A
Altman-Z	3.45

ROIC/WACCN/A

WACC8.29%

2.3 Liquidity

A Current Ratio of 1.64 indicates that GROW should not have too much problems paying its short term obligations.

GROW has a Current ratio of 1.64. This is in the better half of the industry: GROW outperforms 63.37% of its industry peers.

A Quick Ratio of 1.64 indicates that GROW should not have too much problems paying its short term obligations.

Looking at the Quick ratio, with a value of 1.64, GROW is in the better half of the industry, outperforming 66.34% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.64
Quick Ratio	1.64

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for GROW have decreased strongly by -104.16% in the last year.

The Revenue has decreased by -0.80% in the past year.

The Revenue has been growing slightly by 4.14% on average over the past years.

EPS 1Y (TTM)-104.16%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-101.22%

Revenue 1Y (TTM)-0.8%

Revenue growth 3Y1.48%

Revenue growth 5Y4.14%

Sales Q2Q%-4.74%

3.2 Future

GROW is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.22% yearly.

The Revenue is expected to grow by 5.49% on average over the next years.

EPS Next Y25%

EPS Next 2Y28.7%

EPS Next 3Y21.22%

EPS Next 5YN/A

Revenue Next Year4.16%

Revenue Next 2Y5.03%

Revenue Next 3Y5.49%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

GROW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GROW. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

GROW's earnings are expected to grow with 21.22% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y28.7%

EPS Next 3Y21.22%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

GROW has a Yearly Dividend Yield of 10.56%, which is a nice return.

Compared to an average industry Dividend Yield of 2.06, GROW pays a better dividend. On top of this GROW pays more dividend than 100.00% of the companies listed in the same industry.

GROW's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.

		Industry Rank	Sector Rank
Dividend Yield	10.56%

5.2 History

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

The earnings of GROW are negative and hence is the payout ratio. GROW will probably not be able to sustain this dividend level.

DP-824.53%

EPS Next 2Y28.7%

EPS Next 3Y21.22%

More info and screens

Find the best dividend stocks

Show peers with best dividend

GROWENS SPA

BIT:GROW (9/9/2025, 7:00:00 PM)

3.39

-0.03 (-0.88%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners6%

Inst Owner ChangeN/A

Ins Owners51.06%

Ins Owner ChangeN/A

Market Cap52.17M

Analysts44

Price Target4.39 (29.5%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	10.56%

Yearly Dividend1.58

Dividend Growth(5Y)N/A

DP-824.53%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-25.22%

PT rev (3m)-25.22%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)14.29%

EPS NY rev (3m)14.29%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-1.52%

Revenue NY rev (3m)-1.52%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.7
P/FCF	N/A
P/OCF	N/A
P/B	1.51
P/tB	2.73
EV/EBITDA	N/A

EPS(TTM)-0.19

EYN/A

EPS(NY)-0.12

Fwd EYN/A

FCF(TTM)-0.58

FCFYN/A

OCF(TTM)-0.27

OCFYN/A

SpS4.84

BVpS2.24

TBVpS1.24

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-4.08%
ROE	-7.05%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	22.38%
FCFM	N/A

ROA(3y)20.87%

ROA(5y)12.86%

ROE(3y)26.81%

ROE(5y)17.18%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-9.85%

GM growth 5Y-2.53%

F-Score4

Asset Turnover1.25

Health

		Industry Rank	Sector Rank
Debt/Equity	0.06
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	121.78%
Cap/Sales	6.34%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.64
Quick Ratio	1.64
Altman-Z	3.45

F-Score4

WACC8.29%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-104.16%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-101.22%

EPS Next Y25%

EPS Next 2Y28.7%

EPS Next 3Y21.22%

EPS Next 5YN/A

Revenue 1Y (TTM)-0.8%

Revenue growth 3Y1.48%

Revenue growth 5Y4.14%

Sales Q2Q%-4.74%

Revenue Next Year4.16%

Revenue Next 2Y5.03%

Revenue Next 3Y5.49%

Revenue Next 5YN/A

EBIT growth 1Y-9.8%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year112.5%

EBIT Next 3Y37.06%

EBIT Next 5YN/A

FCF growth 1Y-56.63%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y26.5%

OCF growth 3YN/A

OCF growth 5YN/A

GROWENS SPA (GROW.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens